MADE IN USA INC. Announces Non-Binding Strategic Partnership with Rosalind, Inc. to Enter Healthcare Data Market
summarizeSummary
MADE IN USA INC. has signed a non-binding term sheet with Rosalind, Inc. to form a new entity, Rosalind Systems, Inc., aiming to expand its data wallet technology into the healthcare and life sciences sector.
check_boxKey Events
-
Strategic Partnership Announced
MADE IN USA INC. executed a non-binding term sheet with Rosalind, Inc. to form Rosalind Systems, Inc., a new operating entity.
-
Entry into Healthcare Data Market
The new entity will integrate USDW's data wallet and certification technologies with Rosalind's platform to expand into healthcare, life sciences, and data infrastructure.
-
Framework for Capital Formation
The proposed structure is designed to support capital formation and expansion into areas including biopharma, clinical data, and public health infrastructure.
-
Non-Binding Agreement
The term sheet is non-binding and subject to the negotiation and execution of definitive agreements, completion of financing, and satisfaction of other customary closing conditions.
auto_awesomeAnalysis
This strategic initiative is significant for MADE IN USA INC., especially given its previously disclosed "going concern" issues and zero cash. The proposed partnership with Rosalind, Inc. to create Rosalind Systems, Inc. outlines a potential path for growth and capital formation in the critical healthcare data sector. While the term sheet is non-binding and subject to definitive agreements and financing, it signals a strategic direction and potential for future revenue streams and investment, which is crucial for the company's long-term viability. The focus on verifiable, trusted data in healthcare aligns with current market needs.
At the time of this filing, USDW was trading at $0.13 on OTC in the Technology sector. The 52-week trading range was $0.03 to $0.03. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.